Effects of E-care Protocol in Patients With Coronary Artery Bypass Graft

ConditionCABG

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age45-70

SponsorRiphah International University

About this trial

Coronary artery disease (CAD) is a heart disease caused by the buildup of plaque inside the coronary arteries that restricts blood flow to the heart which leads to heart attack. If it involve more than one artery it will be more critical so the preferred treatment will be coronary artery bypass graft. Respiratory failure after Coronary Artery Bypass Grafting (CABG) is a serious complication with multifactorial causes i.e. pneumonia and atelectasis in inpatients.

Postoperative pulmonary complications will be diagnosed using the Melbourne Group Scale (MGS), applied daily from postoperative day 1 to day 7. A score of ≥4 positive criteria will be used to identify PPCs. The scale's criteria will include chest radiograph findings, oxygen saturation, sputum characteristics, inflammatory markers, and ventilation data, physician diagnosis of pneumonia, readmission to ICU for respiratory reasons, prolong ventilation\> 24 hours, unplanned use of non-invasive ventilation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male and female of >45 years diagnosed with CAD and are undergone Coronary Artery Bypass Graft with stable circulation.

Stable vitals.

With normal cognition and being able to cooperate with the CR training.

Agreed to participate in the trial and signed the consent for .

Disqualifiers

Pregnant

Undergoing aortic surgery or equivalent surgery within 6 months

History of cardiogenic shock or sudden cardiac arrest and severe hypertension

Having complications with persistent ischemia, hemodynamic impairment, or at risk of arterial occlusion with massive myocardial infarction

Trial design

Design model

Parallel

Treatments tested in this trial

IMT Threshold device
Device
Group A will receive standard rehabilitation treatment for inpatients. This includes the physical reconditioning, promote patient independence, Provide education about lifestyle changes and respiratory muscle strength. For example Day 1-2(Sitting up in bed or in a chair, Breathing exercises (incentive spirometer) and Coughing with pillow support (to protect the sternum).Day 2-3(Standing and walking short distances with assistance and Gentle range-of- motion (ROM) exercises. Day 4-5 (Walk longer distances (50-100 meters) and Stair climbing (if appropriate). It's necessary to monitor the vital signs (HR, BP, O2 saturation), pain levels, wound inspection and signs of orthostatic intolerance or arrhythmias. 6.1 IMT (Inspiratory muscle training) via use of IMT threshold Device: In comfortable sitting position IMT threshold device will be applied to the patient. Device will properly fitted to the patients mouth and set the resistance according to the patient respiratory muscle strength af

Treatment groups

42 Participants

are divided into 2 treatment groups

Group A: Group BActive comparator 1 intervention

Group B: Group ANo intervention 0 interventions

Trial outcomes

Primary outcomes

change in Length of stay

Length of stay in ward will be noted

Time frame

Total days 7

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Riphah International University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: